Eclampsia Clinical Trial
Official title:
Incidence and Neonatal Outcome of Eclamptic Parturient : a 13-years Retrospective Study From a Single Tertiary Care Center Anesthetic Aspect.
NCT number | NCT04160923 |
Other study ID # | SIRB 390/2017 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 2016 |
Est. completion date | May 2019 |
Verified date | November 2019 |
Source | Siriraj Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Eclampsia is a rare but serious disease that can happen during the pregnancy. Both general and regional anesthesia can both be performed in eclamptic patients. Eclamptic patients has greater risk if undergo general anesthesia such as risks associated with general anesthesia in pregnancy and also cerebral hemorrhage risks from hypertension during laryngoscope application and thrombocytopenia that can happen in eclamptic patients. So, most of Anesthesiologists tend to avoid performing general anesthesia in these patients. But spinal anesthesia also has side effects such as hypotension or epidural hematoma. And nowadays there's minimal evidence on suitable anesthesia in eclamptic patients. Our study wants to review on how choice of anesthesia affects these patients both mothers and their neonates
Status | Completed |
Enrollment | 46 |
Est. completion date | May 2019 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patient who diagnosed with eclampsia. Exclusion Criteria: - Incomplete medical record. |
Country | Name | City | State |
---|---|---|---|
Thailand | Department of Anesthesiology, Siriraj Hospital, Mahidol University | Bangkok Noi | Bangkok |
Thailand | Pattrapun Wongsripuemtet | Bangkok Noi | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Siriraj Hospital |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The incidence of eclampsia in Siriraj Hospital. | Incidence represent as percent. | 13 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Completed |
NCT05121415 -
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
|
||
Recruiting |
NCT02920593 -
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
|
Phase 4 | |
Recruiting |
NCT02578810 -
PIERS and BIS, sFIT:PIGF, Adrenomedullin
|
||
Completed |
NCT05143710 -
The Clinical and Prognostic Features of PRES
|
||
Completed |
NCT03028194 -
Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia
|
N/A | |
Recruiting |
NCT05678062 -
Point-of-care Ultrasound Abnormalities in Eclampsia
|
N/A | |
Unknown status |
NCT02256995 -
uChek Pilot Study for Urinalysis in the Antenatal Care Setting
|
N/A | |
Completed |
NCT01751945 -
Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project
|
N/A | |
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT06219109 -
Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
|
||
Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
Completed |
NCT02765906 -
Comparing Different Methods of Patient Education on Preeclampsia
|
N/A | |
Recruiting |
NCT01856387 -
The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
|
N/A | |
Recruiting |
NCT03200743 -
Catestatin and Hypertension in Pregnancy
|
N/A | |
Not yet recruiting |
NCT04855513 -
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
|
N/A | |
Completed |
NCT00000534 -
Calcium for Pre-Eclampsia Prevention (CPEP)
|
Phase 3 | |
Recruiting |
NCT05655936 -
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
|
N/A |